Author

K. V. Morris

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Assay:CRISPR screen· 1 Approach:genetic perturbation / CRISPR· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Idris· 1 shared A. M. Davis· 1 shared A. Supramaniam· 1 shared D. T. Clarke· 1 shared G. Kelly· 1 shared G. Shevchenko· 1 shared N. A. McMillan· 1 shared Y. Tayyar· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Idris

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Intranasal delivery of lipid nanoparticle encapsulated SARS-CoV-2 and RSV-targeting siRNAs reduces lung infection

A. Supramaniam, Y. Tayyar, D. T. Clarke, G. Kelly, K. V. Morris, N. A. McMillan, A. Idris

This paper develops an intranasal lipid nanoparticle (LNP) delivery system for siRNAs targeting SARS-CoV-2 and RSV, showing effective reduction of lung infection in mice.

bioRxiv · Jul 25, 2022 · PreprintMicrobiology

Hypoxia-directed tumor targeting of CRISPR/Cas9 and HSV-TK suicide gene therapy using lipid nanoparticles

A. M. Davis, K. V. Morris, G. Shevchenko

This study develops a hypoxia-targeted gene therapy system using CRISPR/Cas9 and HSV-TK delivered via lipid nanoparticles, showing effective tumor cell killing under hypoxia without affecting normoxic cells.

bioRxiv · Sep 30, 2021Cancer Biology